Your browser doesn't support javascript.
loading
Real-world evidence from the non-interventional, prospective, German multicentre PERSIST study of patients with psoriasis after 1 year of treatment with guselkumab.
Gerdes, S; Asadullah, K; Hoffmann, M; Korge, B; Mortazawi, D; Wegner, S; Personke, Y; Gomez, M; Sticherling, M.
Affiliation
  • Gerdes S; Psoriasis Center Kiel, Department of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Asadullah K; Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Hoffmann M; Prof. Dr. med. Asadullah, Hautarztpraxis, Potsdam, Germany.
  • Korge B; Dermatology Practice Dr. Matthias Hoffmann, Witten, Germany.
  • Mortazawi D; Dermatology Practice Dr. Bernhard Korge, Düren, Germany.
  • Wegner S; Dermatology Practice Dr. Dariusch Mortazawi, Remscheid, Germany.
  • Personke Y; Janssen-Cilag GmbH, MAF, Neuss, Germany.
  • Gomez M; Janssen-Cilag GmbH, MAF, Neuss, Germany.
  • Sticherling M; Janssen-Cilag GmbH, MAF, Neuss, Germany.
J Eur Acad Dermatol Venereol ; 36(9): 1568-1577, 2022 Sep.
Article in En | MEDLINE | ID: mdl-35569014
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Quality of Life Type of study: Clinical_trials / Observational_studies Aspects: Patient_preference Limits: Adult / Humans Language: En Journal: J Eur Acad Dermatol Venereol Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Quality of Life Type of study: Clinical_trials / Observational_studies Aspects: Patient_preference Limits: Adult / Humans Language: En Journal: J Eur Acad Dermatol Venereol Year: 2022 Document type: Article